[On the question of preclinical selection of cytostatics in the area of treatment of human tumors].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D006224:Cricetinae; D046508:Culture Techniques; D004273:DNA, Neoplasm / Q000378:metabolism*; D003609:Dactinomycin / Q000494:pharmacology; D003864:Depression, Chemical; D005472:Fluorouracil / Q000494:pharmacology; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008722:Methods; D008727:Methotrexate / Q000494:pharmacology; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D009374:Neoplasms, Experimental / Q000378:metabolism; D012334:RNA, Neoplasm / Q000378:metabolism*; D011877:Radionuclide Imaging; D051381:Rats; D013268:Stimulation, Chemical; D013936:Thymidine / Q000378:metabolism; D014228:Triaziquone / Q000494:pharmacology; D014316:Tritium; D014747:Vinblastine / Q000494:pharmacology; D014750:Vincristine / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; D014316:Tritium; D003609:Dactinomycin; D014750:Vincristine; D014747:Vinblastine; D014228:Triaziquone; D005472:Fluorouracil; D013936:Thymidine; D008727:Methotrexate
Zur Frage der praeklinischen Selektion von Cytostatica im Rahmen der Behandlung menschlicher Rumoren.